Zobrazeno 21 - 30
of 82
pro vyhledávání: '"Katia Mancuso"'
Autor:
Carolina Terragna, Andrea Poletti, Vincenza Solli, Marina Martello, Enrica Borsi, Elena Zamagni, Lucia Pantani, Gaia Mazzocchetti, Ilaria Vigliotta, Silvia Armuzzi, Barbara Taurisano, Paola tacchetti, Katia Mancuso, Serena Rocchi, Ignazia Pistis, Giulia Marzocchi, Nicoletta Testoni, Michele Cavo
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S77-S78
Autor:
Katia Mancuso, Simona Barbato, Elena Zamagni, Michele Cavo, Lucia Pantani, Serena Rocchi, Paola Tacchetti, Ilaria Rizzello
Publikováno v:
Expert review of hematology. 14(12)
Introduction Availability of new classes of novel agents has led to a radical switch in treatment paradigms for newly diagnosed transplant-ineligible multiple myeloma (NDTIMM) patients, providing an opportunity to significantly enhance the depth of r
Autor:
Valerio De Stefano, Lucia Pantani, Sonia Morè, Simona Barbato, Luca Dozza, Michele Cea, Alessio Fusco, Maria Teresa Petrucci, Alessandro Gozzetti, Patrizia Tosi, Michele Cavo, Gabriella De Cicco, Elisabetta Antonioli, Paola Tacchetti, Katia Mancuso, Mattia D'Agostino, Serena Rocchi, Elena Rivolti, Elena Zamagni, Ilaria Rizzello
Publikováno v:
Leukemialymphoma. 62(8)
Subcutaneous (SC) bortezomib-based regimens represent the standard induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma patients. Published data are based principally on intravenous (IV) administr
Autor:
Ilaria Vigliotta, Marina Martello, Silvia Armuzzi, Andrea Poletti, Michele Cavo, Carolina Terragna, Elena Zamagni, Katia Mancuso, Barbara Taurisano, Serena Rocchi, Gaia Mazzocchetti, Paola Tacchetti, Lucia Pantani, Enrica Borsi, Vincenza Solli
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S35-S36
Background MM is a hematological malignancy always evolving from pre-malignant stages, with progressive increase of genomic complexity. MM is characterized by a large abundance of copy number alterations (CNA); many of them, regarded as “driver”,
Autor:
Marina Martello, Michele Cavo, Enrica Borsi, Silvia Armuzzi, Andrea Poletti, Ignazia Pistis, Vincenza Solli, Katia Mancuso, Barbara Taurisano, Lucia Pantani, Elena Zamagni, Carolina Terragna, Serena Rocchi, Paola Tacchetti, Ilaria Vigliotta, Gaia Mazzocchetti
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S4-S5
Introduction Multiple Myeloma (MM) is a genetically complex disease, characterized by the recurrence of several chromosomal aberrations, which impair the disease prognosis. The use of genome-wide technologies has recently highlighted the existence of
Autor:
Giulia Marzocchi, Luca Dozza, Angela Bonalumi, Elisabetta Antonioli, Lucia Pantani, Chiara Di Giovanni Bezzi, Marina Martello, Anna Furlan, Michela Staderini, Elena Zamagni, Mario Petrini, Paola Tacchetti, Michele Cavo, Katia Mancuso, Marco Scalese, Ilaria Rizzello, Gregorio Barilà, Gabriele Buda, Michele Cea, Serena Rocchi, Micol Quaresima
Carfilzomib–lenalidomide–dexamethasone (KRd) has been approved for the treatment of relapsed/refractory multiple myeloma (RRMM). We conducted a retrospective analysis of 197 RRMM patients (pts) between January 2016 and March 2018 in six Italian h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97fea9e4d4d4ad198217daaf8831ae18
http://hdl.handle.net/11585/804597
http://hdl.handle.net/11585/804597
Autor:
Anna Furlan, Marina Martello, Giulia Marzocchi, Michele Cea, Michela Staderini, Lucia Pantani, Mario Petrini, Angela Bonalumi, Gregorio Barilà, Serena Rocchi, Luca Dozza, Elena Zamagni, Michele Cavo, Ilaria Rizzello, Marco Scalese, Gabriele Buda, Chiara Di Giovanni Bezzi, Micol Quaresima, Katia Mancuso, Elisabetta Antonioli, Paola Tacchetti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6855f73c9e2ffbfbc702d56450816bbc
https://doi.org/10.1002/hon.2820/v2/response1
https://doi.org/10.1002/hon.2820/v2/response1
Autor:
Alessio Fusco, Carolina Terragna, Emanuele Favero, Elena Zamagni, Michele Cavo, Barbara Ruffini, Vincenza Solli, Lucia Pantani, Ilaria Rizzello, Gabriella De Cicco, Katia Mancuso, Paola Tacchetti, Margherita Ursi, Marco Talarico, Pier Luigi Zinzani, Giuliana Nepoti, Serena Rocchi, Liliana Gabrielli, Tiziana Lazzarotto
Publikováno v:
Blood
mRNA vaccines BNT162b2 and mRNA1273 are highly effective in preventing SARS-CoV-2 infection and mortality in healthy adults. However, their immunogenicity in immunocompromised Multiple Myeloma (MM) patients is less clear. We performed an observationa
Autor:
Elena Zamagni, Nicoletta Testoni, Luca Dozza, Marina Martello, Alessio Fusco, Carolina Terragna, Paola Tacchetti, Michele Cavo, Serena Rocchi, Giulia Marzocchi, Lucia Pantani, Isola Caratozzolo, Ilaria Rizzello, Enrica Borsi, Gabriella De Cicco, Katia Mancuso
Publikováno v:
Bone marrow transplantation. 55(9)
No abstract available.
Autor:
Luca Dozza, Marina Martello, Serena Rocchi, Mario Boccadoro, Nicoletta Testoni, Luca Nunzio Cifarelli, Agboyi Lakpo, Elena Zamagni, Giulia Marzocchi, Silvia Armuzzi, Michele Cavo, Lucia Pantani, Carolina Terragna, Paola Tacchetti, Anna Marina Liberati, Giuseppe Rossi, Vincenza Solli, Maria Teresa Petrucci, Andrea Poletti, Katia Mancuso, Enrica Borsi, Ilaria Rizzello
BACKGROUND: Multiple Myeloma (MM) maintenance therapy is a low intensive, prolonged treatment, commonly administered to newly diagnosed patients (pts) at the end of front-line regimens. Lenalidomide (LEN) is considered the best available maintenance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65f5a123b462b383c5acae2bf75b3561
http://hdl.handle.net/11585/835139
http://hdl.handle.net/11585/835139